Statistics
Publications
6
Citations
742
H-Index
6
Active since
2003
Jamie Ketas is an author at Cornell University specializing in cancer immunotherapy, monoclonal antibodies, and cancer immunology.
Publications per year
2003–2006
6
6
Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma
John P. Leonard, Morton Coleman, Jamie Ketas et al. · Clinical Cancer Research · 2004 · 227 citations
Pharmacy, Hematology, Pharmacology +17
Epratuzumab: targeting B-cell malignancies through CD22.
Morton Coleman, David M. Goldenberg, Abby B. Siegel et al. · PubMed · 2003 · 47 citations
Medicine, Oncology, Pharmacology +17
1–5 of 6